By analyzing individual cancer cells, researchers from the Université Libre de Bruxelles (ULB) discovered the transcriptional regulators governing epithelial-to-mesenchymal transition (EMT) in tumors and identified key master ...
Jul 16, 2026
0
5
New research from VCU Massey Comprehensive Cancer Center provides evidence for a combination treatment strategy that uses cells' waste-removal functions to target multiple myeloma. The findings, published recently in Cell ...
Jul 14, 2026
0
5
Being overweight and obesity may contribute to significantly more cancer cases than previously thought. This is the conclusion reached by researchers at the German Cancer Research Center (DKFZ). Their analysis shows that ...
Jul 16, 2026
0
5
For patients with newly diagnosed multiple myeloma not undergoing an autologous stem cell transplant, indefinite lenalidomide maintenance has long been standard care despite limited evidence to guide the optimal duration ...
Jul 16, 2026
0
5
A leading-edge immunotherapy may extend survival for patients with one of the most aggressive forms of blood cancer, according to newly published five-year results from a major clinical trial in the Blood Journal. The clinical ...
Jul 14, 2026
0
5
Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and coordinator of powerful immune hubs that form inside tumors and plays a key role in antitumor immunity. ...
Jul 16, 2026
0
5
Weill Cornell Medicine investigators have developed a new AI-based method to assess patients with a form of blood cancer called myelodysplastic neoplasms. The method, published June 30 in Leukemia, compares the physical locations ...
Jul 20, 2026
0
5
Researchers at the University of Liverpool have discovered that SYCP1, a protein previously thought to function only during the production of sperm and eggs, can be reactivated in cancer cells, where it helps tumors survive ...
Jul 15, 2026
0
5
University of Cincinnati Cancer Center researchers led a first-of-a-kind clinical study showing that a cancer treatment known as FLASH, or ultra-high-dose-rate proton beam radiation therapy, safely and effectively reduced ...
Jul 16, 2026
0
5
Researchers have found that, with new treatments for multiple myeloma, a serious type of blood cancer, clinicians should use different criteria to identify patients with poor chances of survival. The study was published online ...
Jul 20, 2026
0
5
